Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
about
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and PerspectivesAntioxidants in liver healthHerbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospectsLiver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.Hepatoprotective activity of chrysin is mediated through TNF-α in chemically-induced acute liver damage: An in vivo study and molecular modeling.Hepatoprotective effects of litchi (Litchi chinensis) procyanidin A2 on carbon tetrachloride-induced liver injury in ICR miceIn vivo efficacy study of milk thistle extract (ETHIS-094™) in STAM™ model of nonalcoholic steatohepatitisEfficacy of lifestyle changes in subjects with non-alcoholic liver steatosis and metabolic syndrome may be improved with an antioxidant nutraceutical: a controlled clinical studyA double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury.Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis.Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis.Food components with antifibrotic activity and implications in prevention of liver disease.Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis.Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
P2860
Q26770933-F8C3592B-CA88-48D3-A1CE-F73547862497Q26799415-8D5E086A-4F60-4E4D-A186-1358AA1830E9Q26828615-24FFBD8C-8DAF-44C2-95B6-136CD110812CQ30374500-6A4A44DB-2F06-4BC8-B94A-771FC70427D6Q33724192-4F45C28C-1C91-4559-AFBC-08B3BAE5364DQ33744444-386E6ACA-2DE7-4B54-8162-87D7AD111EF2Q34727822-C7DAA686-8865-43EA-8B41-5C877E324B27Q35175904-21767535-7F6E-45FF-BB92-2FFB34198DE8Q35786010-A170039E-87E2-4CC4-9D4C-E41AE3A71E29Q35900864-BFCFC01E-3B28-4F79-89B5-58BEF32798A9Q37575764-7647C321-7F27-409B-9269-3B42CA31BD35Q38326327-4EA6B828-1D9A-48E9-B842-2D3690EC5015Q47264700-B5D5C5F3-DC37-4EE7-8F3F-E0B1E1D4760FQ47380801-F3CD197D-6189-4F1B-9027-8DF17D872B71Q58753073-05D20373-875D-4750-B5A5-DDA57430FFE6
P2860
Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Silymarin suppresses hepatic s ...... olated hepatic stellate cells.
@ast
Silymarin suppresses hepatic s ...... olated hepatic stellate cells.
@en
type
label
Silymarin suppresses hepatic s ...... olated hepatic stellate cells.
@ast
Silymarin suppresses hepatic s ...... olated hepatic stellate cells.
@en
prefLabel
Silymarin suppresses hepatic s ...... olated hepatic stellate cells.
@ast
Silymarin suppresses hepatic s ...... olated hepatic stellate cells.
@en
P2093
P2860
P356
P1476
Silymarin suppresses hepatic s ...... olated hepatic stellate cells.
@en
P2093
Jin-Woo Lee
Joon Mi Kim
Jung Il Lee
Su-Geun Yang
Young Soo Kim
P2860
P304
P356
10.3892/IJMM.2012.1029
P577
2012-06-14T00:00:00Z